{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/ROIV/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-19T17:54:39.480Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":4036,"canonical_name":"Roivant Sciences Ltd.","cik":"0001635088","uei":null,"lei":null,"duns":null,"ticker":"ROIV"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":112},"count":100,"timeline":[{"ts":"2026-10-05","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-10-05","url_slug":"/sec/cik-0001635088/4/0001807359-26-000018","accession_number":"0001807359-26-000018","importance":30},{"ts":"2026-10-02","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-10-02","url_slug":"/sec/cik-0001635088/4/0001140361-26-038474","accession_number":"0001140361-26-038474","importance":30},{"ts":"2026-10-02","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-10-02","url_slug":"/sec/cik-0001635088/4/0001140361-26-038475","accession_number":"0001140361-26-038475","importance":30},{"ts":"2026-10-02","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-10-02","url_slug":"/sec/cik-0001635088/4/0001635088-26-000108","accession_number":"0001635088-26-000108","importance":30},{"ts":"2026-10-02","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-10-02","url_slug":"/sec/cik-0001635088/4/0001635088-26-000109","accession_number":"0001635088-26-000109","importance":30},{"ts":"2026-09-30","kind":"sec.filing","form_type":"144","title":"144 — Roivant Sciences Ltd. — 2026-09-30","url_slug":"/sec/cik-0001635088/144/0001965301-26-000150","accession_number":"0001965301-26-000150","importance":30},{"ts":"2026-09-22","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-09-22","url_slug":"/sec/cik-0001635088/4/0001140361-26-037363","accession_number":"0001140361-26-037363","importance":30},{"ts":"2026-09-22","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-09-22","url_slug":"/sec/cik-0001635088/4/0001635088-26-000104","accession_number":"0001635088-26-000104","importance":30},{"ts":"2026-09-18","kind":"sec.filing","form_type":"8-K","title":"8-K — Roivant Sciences Ltd. — 2026-09-18","url_slug":"/sec/cik-0001635088/8-k/0001635088-26-000095","accession_number":"0001635088-26-000095","importance":35},{"ts":"2026-09-18","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-09-18","url_slug":"/sec/cik-0001635088/4/0001635088-26-000099","accession_number":"0001635088-26-000099","importance":30},{"ts":"2026-09-18","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-09-18","url_slug":"/sec/cik-0001635088/4/0001635088-26-000102","accession_number":"0001635088-26-000102","importance":30},{"ts":"2026-09-18","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-09-18","url_slug":"/sec/cik-0001635088/4/0001807359-26-000016","accession_number":"0001807359-26-000016","importance":30},{"ts":"2026-09-17","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-09-17","url_slug":"/sec/cik-0001635088/4/0001807359-26-000014","accession_number":"0001807359-26-000014","importance":30},{"ts":"2026-09-15","kind":"sec.filing","form_type":"144","title":"144 — Roivant Sciences Ltd. — 2026-09-15","url_slug":"/sec/cik-0001635088/144/0001950047-26-009506","accession_number":"0001950047-26-009506","importance":30},{"ts":"2026-09-14","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-09-14","url_slug":"/sec/cik-0001635088/4/0001140361-26-036535","accession_number":"0001140361-26-036535","importance":30},{"ts":"2026-09-14","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-09-14","url_slug":"/sec/cik-0001635088/4/0001635088-26-000092","accession_number":"0001635088-26-000092","importance":30},{"ts":"2026-09-14","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-09-14","url_slug":"/sec/cik-0001635088/4/0001807359-26-000012","accession_number":"0001807359-26-000012","importance":30},{"ts":"2026-09-08","kind":"sec.filing","form_type":"8-K","title":"8-K — Roivant Sciences Ltd. — 2026-09-08","url_slug":"/sec/cik-0001635088/8-k/0001140361-26-035859","accession_number":"0001140361-26-035859","importance":35},{"ts":"2026-09-01","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-09-01","url_slug":"/sec/cik-0001635088/4/0001140361-26-035375","accession_number":"0001140361-26-035375","importance":30},{"ts":"2026-08-28","kind":"sec.filing","form_type":"8-K","title":"8-K — Roivant Sciences Ltd. — 2026-08-28","url_slug":"/sec/cik-0001635088/8-k/0001140361-26-034854","accession_number":"0001140361-26-034854","importance":35},{"ts":"2026-08-28","kind":"sec.filing","form_type":"144","title":"144 — Roivant Sciences Ltd. — 2026-08-28","url_slug":"/sec/cik-0001635088/144/0001965301-26-000133","accession_number":"0001965301-26-000133","importance":30},{"ts":"2026-08-27","kind":"sec.filing","form_type":"8-K","title":"8-K — Roivant Sciences Ltd. — 2026-08-27","url_slug":"/sec/cik-0001635088/8-k/0001140361-26-034735","accession_number":"0001140361-26-034735","importance":35},{"ts":"2026-08-24","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-08-24","url_slug":"/sec/cik-0001635088/4/0001140361-26-034238","accession_number":"0001140361-26-034238","importance":30},{"ts":"2026-08-24","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-08-24","url_slug":"/sec/cik-0001635088/4/0001140361-26-034239","accession_number":"0001140361-26-034239","importance":30},{"ts":"2026-08-21","kind":"sec.filing","form_type":"144","title":"144 — Roivant Sciences Ltd. — 2026-08-21","url_slug":"/sec/cik-0001635088/144/0001950047-26-008512","accession_number":"0001950047-26-008512","importance":30},{"ts":"2026-08-21","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-08-21","url_slug":"/sec/cik-0001635088/4/0001140361-26-034066","accession_number":"0001140361-26-034066","importance":30},{"ts":"2026-08-20","kind":"sec.filing","form_type":"144","title":"144 — Roivant Sciences Ltd. — 2026-08-20","url_slug":"/sec/cik-0001635088/144/0001950047-26-008467","accession_number":"0001950047-26-008467","importance":30},{"ts":"2026-08-19","kind":"sec.filing","form_type":"144","title":"144 — Roivant Sciences Ltd. — 2026-08-19","url_slug":"/sec/cik-0001635088/144/0001950047-26-008392","accession_number":"0001950047-26-008392","importance":30},{"ts":"2026-08-18","kind":"sec.filing","form_type":"144","title":"144 — Roivant Sciences Ltd. — 2026-08-18","url_slug":"/sec/cik-0001635088/144/0001950047-26-008341","accession_number":"0001950047-26-008341","importance":30},{"ts":"2026-08-18","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-08-18","url_slug":"/sec/cik-0001635088/4/0001140361-26-033637","accession_number":"0001140361-26-033637","importance":30},{"ts":"2026-08-17","kind":"sec.filing","form_type":"144","title":"144 — Roivant Sciences Ltd. — 2026-08-17","url_slug":"/sec/cik-0001635088/144/0001950047-26-008265","accession_number":"0001950047-26-008265","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"144","title":"144 — Roivant Sciences Ltd. — 2026-08-14","url_slug":"/sec/cik-0001635088/144/0001950047-26-008125","accession_number":"0001950047-26-008125","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Roivant Sciences Ltd. — 2026-08-13","url_slug":"/sec/cik-0001635088/schedule-13g-a/0000895421-26-000250","accession_number":"0000895421-26-000250","importance":30},{"ts":"2026-08-06","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Roivant Sciences Ltd. — 2026-08-06","url_slug":"/sec/cik-0001635088/10-q/0001635088-26-000090","accession_number":"0001635088-26-000090","importance":45},{"ts":"2026-08-06","kind":"sec.filing","form_type":"8-K","title":"8-K — Roivant Sciences Ltd. — 2026-08-06","url_slug":"/sec/cik-0001635088/8-k/0001635088-26-000088","accession_number":"0001635088-26-000088","importance":35},{"ts":"2026-07-29","kind":"sec.filing","form_type":"DEF 14A","title":"DEF 14A — Roivant Sciences Ltd. — 2026-07-29","url_slug":"/sec/cik-0001635088/def-14a/0001140361-26-029955","accession_number":"0001140361-26-029955","importance":40},{"ts":"2026-07-29","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-07-29","url_slug":"/sec/cik-0001635088/4/0001140361-26-030107","accession_number":"0001140361-26-030107","importance":30},{"ts":"2026-07-29","kind":"sec.filing","form_type":"ARS","title":"ARS — Roivant Sciences Ltd. — 2026-07-29","url_slug":"/sec/cik-0001635088/ars/0001140361-26-029957","accession_number":"0001140361-26-029957","importance":30},{"ts":"2026-07-29","kind":"sec.filing","form_type":"DEFA14A","title":"DEFA14A — Roivant Sciences Ltd. — 2026-07-29","url_slug":"/sec/cik-0001635088/defa14a/0001140361-26-029956","accession_number":"0001140361-26-029956","importance":30},{"ts":"2026-07-27","kind":"sec.insider.s","reporter":"Venker Eric","title":"President & Immunovant CEO","shares":200000,"price_per_share":34.95,"usd_value":6990000,"security_title":"Common Shares","importance":41.99},{"ts":"2026-07-27","kind":"sec.filing","form_type":"144","title":"144 — Roivant Sciences Ltd. — 2026-07-27","url_slug":"/sec/cik-0001635088/144/0001965301-26-000094","accession_number":"0001965301-26-000094","importance":30},{"ts":"2026-07-27","kind":"sec.insider.m","reporter":"Venker Eric","title":"President & Immunovant CEO","shares":200000,"price_per_share":3.85,"usd_value":770000,"security_title":"Common Shares","importance":15.77},{"ts":"2026-07-21","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-07-21","url_slug":"/sec/cik-0001635088/4/0001140361-26-029192","accession_number":"0001140361-26-029192","importance":30},{"ts":"2026-07-17","kind":"sec.insider.405","reporter":"MOMTAZEE JAMES C","title":null,"shares":405,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-07-17","kind":"sec.insider.543","reporter":"Epperly Melissa B,","title":null,"shares":543,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-07-17","kind":"sec.insider.775","reporter":"Oren Ilan","title":null,"shares":775,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-07-17","kind":"sec.insider.a","reporter":"MOMTAZEE JAMES C","title":null,"shares":405,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-07-17","kind":"sec.insider.a","reporter":"Oren Ilan","title":null,"shares":775,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-07-17","kind":"sec.insider.a","reporter":"Epperly Melissa B,","title":null,"shares":543,"price_per_share":0,"usd_value":0,"security_title":"Common Shares","importance":15},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-07-02","url_slug":"/sec/cik-0001635088/4/0001635088-26-000075","accession_number":"0001635088-26-000075","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-07-02","url_slug":"/sec/cik-0001635088/4/0001635088-26-000077","accession_number":"0001635088-26-000077","importance":30},{"ts":"2026-07-02","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-07-02","url_slug":"/sec/cik-0001635088/4/0001635088-26-000079","accession_number":"0001635088-26-000079","importance":30},{"ts":"2026-07-01","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-07-01","url_slug":"/sec/cik-0001635088/4/0001807359-26-000010","accession_number":"0001807359-26-000010","importance":30},{"ts":"2026-06-30","kind":"sec.insider.s","reporter":"MANCHESTER KEITH S","title":null,"shares":200000,"price_per_share":35.45,"usd_value":7090000,"security_title":"Common Shares","importance":42.09},{"ts":"2026-06-30","kind":"sec.form144","reporter":"KEITH S MANCHESTER","title":"Director","shares":200000,"usd_value":7090280,"security_title":"Common","approx_sale_date":"2026-06-30","accession_number":"0001950047-26-006641","importance":41.418056},{"ts":"2026-06-30","kind":"sec.form144","reporter":"MEGHAN FITZGERALD","title":"Director","shares":10000,"usd_value":347300,"security_title":"Common","approx_sale_date":"2026-06-30","accession_number":"0001950047-26-006657","importance":40.06946},{"ts":"2026-06-30","kind":"sec.insider.s","reporter":"MANCHESTER KEITH S","title":null,"shares":12380,"price_per_share":35.28,"usd_value":436766,"security_title":"Common Shares","importance":35.4367664},{"ts":"2026-06-30","kind":"sec.insider.s","reporter":"QVT Financial LP","title":null,"shares":12380,"price_per_share":35.28,"usd_value":436766,"security_title":"Common Shares","importance":35.4367664},{"ts":"2026-06-30","kind":"sec.insider.s","reporter":"Gold Daniel Allen","title":null,"shares":12380,"price_per_share":35.28,"usd_value":436766,"security_title":"Common Shares","importance":35.4367664},{"ts":"2026-06-30","kind":"sec.insider.s","reporter":"Fitzgerald Meghan","title":null,"shares":10000,"price_per_share":34.9,"usd_value":349000,"security_title":"Common Shares","importance":35.349},{"ts":"2026-06-30","kind":"sec.filing","form_type":"144","title":"144 — Fitzgerald Meghan — 2026-06-30","url_slug":"/sec/cik-0001349297/144/0001950047-26-006657","accession_number":"0001950047-26-006657","importance":30},{"ts":"2026-06-30","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-06-30","url_slug":"/sec/cik-0001635088/4/0001193125-26-291163","accession_number":"0001193125-26-291163","importance":30},{"ts":"2026-06-30","kind":"sec.insider.f","reporter":"Gline Matthew","title":"CEO","shares":76171,"price_per_share":35.39,"usd_value":2695692,"security_title":"Common Shares","importance":17.69569169},{"ts":"2026-06-30","kind":"sec.insider.f","reporter":"Sukhatme Mayukh","title":"President & CIO","shares":46878,"price_per_share":35.39,"usd_value":1659012,"security_title":"Common Shares","importance":16.65901242},{"ts":"2026-06-30","kind":"sec.insider.f","reporter":"Torti Frank","title":"President and Vant Chair","shares":40310,"price_per_share":35.39,"usd_value":1426571,"security_title":"Common Shares","importance":16.4265709},{"ts":"2026-06-30","kind":"sec.insider.12380","reporter":"QVT Financial LP","title":null,"shares":12380,"price_per_share":35.28,"usd_value":436766,"security_title":"Common Shares","importance":15.4367664},{"ts":"2026-06-30","kind":"sec.insider.m","reporter":"Fitzgerald Meghan","title":null,"shares":10000,"price_per_share":8.8,"usd_value":88000,"security_title":"Common Shares","importance":15.088},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"MANCHESTER KEITH S","title":null,"shares":600000,"price_per_share":34.59,"usd_value":20754000,"security_title":"Common Shares","importance":55.754000000000005},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"QVT Financial LP","title":null,"shares":600000,"price_per_share":34.59,"usd_value":20754000,"security_title":"Common Shares","importance":55.754000000000005},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Gold Daniel Allen","title":null,"shares":600000,"price_per_share":34.59,"usd_value":20754000,"security_title":"Common Shares","importance":55.754000000000005},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"MANCHESTER KEITH S","title":null,"shares":200000,"price_per_share":34.44,"usd_value":6888000,"security_title":"Common Shares","importance":41.888},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"QVT Financial LP","title":null,"shares":200000,"price_per_share":34.44,"usd_value":6888000,"security_title":"Common Shares","importance":41.888},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Gold Daniel Allen","title":null,"shares":200000,"price_per_share":34.44,"usd_value":6888000,"security_title":"Common Shares","importance":41.888},{"ts":"2026-06-29","kind":"sec.form144","reporter":"MELISSA  EPPERLY","title":"Director","shares":17750,"usd_value":604743,"security_title":"Common","approx_sale_date":"2026-06-29","accession_number":"0001950047-26-006594","importance":40.1209485},{"ts":"2026-06-29","kind":"sec.insider.600000","reporter":"QVT Financial LP","title":null,"shares":600000,"price_per_share":34.59,"usd_value":20754000,"security_title":"Common Shares","importance":35.754000000000005},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Epperly Melissa B,","title":null,"shares":15002,"price_per_share":34.32,"usd_value":514869,"security_title":"Common Shares","importance":35.51486864},{"ts":"2026-06-29","kind":"sec.insider.s","reporter":"Epperly Melissa B,","title":null,"shares":2748,"price_per_share":34.71,"usd_value":95383,"security_title":"Common Shares","importance":35.09538308},{"ts":"2026-06-29","kind":"sec.filing","form_type":"144","title":"144 — Roivant Sciences Ltd. — 2026-06-29","url_slug":"/sec/cik-0001635088/144/0001950047-26-006594","accession_number":"0001950047-26-006594","importance":30},{"ts":"2026-06-29","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-06-29","url_slug":"/sec/cik-0001635088/4/0001635088-26-000073","accession_number":"0001635088-26-000073","importance":30},{"ts":"2026-06-29","kind":"sec.insider.200000","reporter":"QVT Financial LP","title":null,"shares":200000,"price_per_share":34.44,"usd_value":6888000,"security_title":"Common Shares","importance":21.887999999999998},{"ts":"2026-06-29","kind":"sec.insider.m","reporter":"Epperly Melissa B,","title":null,"shares":17750,"price_per_share":4.46,"usd_value":79165,"security_title":"Common Shares","importance":15.079165},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Sukhatme Mayukh","title":"President & CIO","shares":500000,"price_per_share":34.08,"usd_value":17040000,"security_title":"Common Shares","importance":52.04},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"MANCHESTER KEITH S","title":null,"shares":325000,"price_per_share":34.07,"usd_value":11072750,"security_title":"Common Shares","importance":46.07275},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"QVT Financial LP","title":null,"shares":325000,"price_per_share":34.07,"usd_value":11072750,"security_title":"Common Shares","importance":46.07275},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Gold Daniel Allen","title":null,"shares":325000,"price_per_share":34.07,"usd_value":11072750,"security_title":"Common Shares","importance":46.07275},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"MANCHESTER KEITH S","title":null,"shares":300783,"price_per_share":33.92,"usd_value":10202559,"security_title":"Common Shares","importance":45.20255936},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"QVT Financial LP","title":null,"shares":300783,"price_per_share":33.92,"usd_value":10202559,"security_title":"Common Shares","importance":45.20255936},{"ts":"2026-06-26","kind":"sec.insider.s","reporter":"Gold Daniel Allen","title":null,"shares":300783,"price_per_share":33.92,"usd_value":10202559,"security_title":"Common Shares","importance":45.20255936},{"ts":"2026-06-26","kind":"sec.form144","reporter":"MAYUKH SUKHATME","title":"Officer, Director","shares":500000,"usd_value":17039650,"security_title":"Common","approx_sale_date":"2026-06-26","accession_number":"0001950047-26-006528","importance":43.40793},{"ts":"2026-06-26","kind":"sec.filing","form_type":"144","title":"144 — Roivant Sciences Ltd. — 2026-06-26","url_slug":"/sec/cik-0001635088/144/0001950047-26-006528","accession_number":"0001950047-26-006528","importance":30},{"ts":"2026-06-26","kind":"sec.filing","form_type":"4","title":"4 — Roivant Sciences Ltd. — 2026-06-26","url_slug":"/sec/cik-0001635088/4/0001635088-26-000071","accession_number":"0001635088-26-000071","importance":30},{"ts":"2026-06-26","kind":"sec.insider.325000","reporter":"QVT Financial LP","title":null,"shares":325000,"price_per_share":34.07,"usd_value":11072750,"security_title":"Common Shares","importance":26.07275},{"ts":"2026-06-26","kind":"sec.insider.300783","reporter":"QVT Financial LP","title":null,"shares":300783,"price_per_share":33.92,"usd_value":10202559,"security_title":"Common Shares","importance":25.202559360000002},{"ts":"2026-06-26","kind":"sec.insider.m","reporter":"Sukhatme Mayukh","title":"President & CIO","shares":500000,"price_per_share":3.85,"usd_value":1925000,"security_title":"Common Shares","importance":16.925},{"ts":"2026-06-25","kind":"sec.insider.s","reporter":"Sukhatme Mayukh","title":"President & CIO","shares":500000,"price_per_share":34.13,"usd_value":17065000,"security_title":"Common Shares","importance":52.065},{"ts":"2026-06-25","kind":"sec.form144","reporter":"MAYUKH SUKHATME","title":"Officer, Director","shares":500000,"usd_value":17066500,"security_title":"Common","approx_sale_date":"2026-06-25","accession_number":"0001950047-26-006517","importance":43.4133},{"ts":"2026-06-25","kind":"sec.filing","form_type":"144","title":"144 — Roivant Sciences Ltd. — 2026-06-25","url_slug":"/sec/cik-0001635088/144/0001950047-26-006517","accession_number":"0001950047-26-006517","importance":30},{"ts":"2026-06-25","kind":"sec.insider.m","reporter":"Sukhatme Mayukh","title":"President & CIO","shares":500000,"price_per_share":3.85,"usd_value":1925000,"security_title":"Common Shares","importance":16.925},{"ts":"2026-06-24","kind":"sec.form144","reporter":"Venker Eric","title":"Officer","shares":200000,"usd_value":6631659,"security_title":"Common","approx_sale_date":"2026-06-24","accession_number":"0001965301-26-000079","importance":41.326331816},{"ts":"2026-06-24","kind":"sec.insider.s","reporter":"Venker Eric","title":"President & Immunovant CEO","shares":153766,"price_per_share":33.05,"usd_value":5081966,"security_title":"Common Shares","importance":40.0819663}]}